4//SEC Filing
Townsend Richard Nolan 4
Accession 0001415889-25-005113
CIK 0001907108other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 5:10 PM ET
Size
4.9 KB
Accession
0001415889-25-005113
Insider Transaction Report
Form 4
Townsend Richard Nolan
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-02-19$4.41/sh−4,326$19,091→ 220,119 total
Footnotes (2)
- [F1]Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").
- [F2]Includes 136,562 RSUs.
Documents
Issuer
Lexeo Therapeutics, Inc.
CIK 0001907108
Entity typeother
Related Parties
1- filerCIK 0001995218
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 5:10 PM ET
- Size
- 4.9 KB